David E. Martin - Publications, H-index & Citations

David E. Martin

Trippbio

56H指数

306论文数

1.3W被引数

收录论文 69

发表时间

Intersection of inflammation and viral replication: the central role of MAPK signaling in viral respiratory infections

Frontiers in Microbiology

IF4.5

2026-01-24

OAAI

Ralph A. Tripp; Les P. Jones; David E. Martin

Evaluation of Probenecid Against Filovirus Replication in Vero E6 Cells 评估Probenecid对Filovirus在Vero E6细胞中复制的影响

Viruses 2026, Vol. 18, Page 43

IF3.5

2025-12-27

OAAI

Kendra Alfson; Ricardo Carrion, Jr.; Ralph A. Tripp; Chris Cirimotich; David E. Martin

Probenecid Treatment Inhibits Replication of the Edmonston Measles Virus Strain in Vero Cells 丙磺舒处理抑制Edmonston麻疹病毒株在Vero细胞中的复制

VIRUSES-BASEL

IF3.5

2025-11-05

OAAI

Murray, Jackelyn; Martin, David E.; Tripp, Ralph A.

Chloroindazole based estrogen receptor β ligands with favorable pharmacokinetics promote functional remyelination and visual recovery 基于Chloroindazole的雌激素受体β配体，具有有利的药代动力学特性，可促进功能性髓鞘再生和视觉恢复

Scientific Reports

IF3.9

2025-10-08

OAAI

Micah Feri; Sung Hoon Kim; Flavio D. Cardenas; Alyssa M. Anderson; Brandon T. Poole; Devang Deshpande; Shane Desfor; Kelley C. Atkinson; Stephanie R. Peterson; Kendall W. Nettles; Jerome C. Nwachukwu; Moyinoluwa T. Ajayi; Fernando Beltran; David E. Martin; Julio Tapia; Carol D. Curtis; Martin I. Garcia-Castro; Benita S. Katzenellenbogen; John A. Katzenellenbogen; Seema K. Tiwari-Woodruff

Probenecid Inhibits NLRP3 Inflammasome Activity and Mitogen-Activated Protein Kinases (MAPKs)Probenecid 抑制 NLRP3 炎症小体活性以及丝裂原活化蛋白激酶（MAPKs）。

BIOMOLECULES

IF4.8

2025-04-01

OAAI

Jones, Les P.; Martin, David E.; Murray, Jackelyn; Sancilio, Fred; Tripp, Ralph A.

Pharmacology of Antiviral Drugs 抗病毒药物药理学

VIRUSES-BASEL

IF3.5

2025-03-24

OAAI

Martin, David E.

Evaluating Probenecid or Oseltamivir Inhibition of Influenza A Virus Replication Through Plaque Assay or Fluorescent Focus Assay Using Non-Structural Protein 1-H1N1 Venus Reporter Virus

VIRUSES-BASEL

IF3.5

2025-02-27

OAAI

Murray, Jackelyn; Nogales, Aitor; Martinez-Sobrido, Luis; Martin, David E.; Sancilio, Fred D.; Tripp, Ralph A.

Antiviral agents and therapeutics against respiratory viruses

EXPERT OPINION ON INVESTIGATIONAL DRUGS

IF4.1

2024-09-08

PREAI

Tripp, Ralph A.; Martin, David E.

Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice

VIRUSES-BASEL

IF3.5

2024-07-06

OAAI

Bergeron, Harrison C.; Crabtree, Jackelyn; Nagy, Tamas; Martin, David E.; Tripp, Ralph A.

Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice 丙磺舒在体外和小鼠体内抑制甲型 (H5N1) 和甲型 (H7N9) 流感病毒

VIRUSES-BASEL

IF3.5

2024-01-19

OAAI

Murray, Jackelyn; Martin, David E.; Hosking, Sarah; Orr-Burks, Nichole; Hogan, Robert J.; Tripp, Ralph A.

Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication

VIRUSES-BASEL

IF3.5

2023-11-30

OAAI

Murray, Jackelyn; Martin, David E.; Sancilio, Fred D.; Tripp, Ralph A.

Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19 筛选具有广谱，宿主导向的抗病毒活性的药物: 开发丙磺舒用于新型冠状病毒肺炎的经验教训

VIRUSES-BASEL

IF3.5

2023-11-14

OAAI

Tripp, Ralph A.; Martin, David E.

Inhibition of T-cell activity in alopecia areata: recent developments and new directions

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-11-06

OAAI

Passeron, Thierry; King, Brett; Seneschal, Julien; Steinhoff, Martin; Jabbari, Ali; Ohyama, Manabu; Tobin, Desmond J.; Randhawa, Simran; Winkler, Aaron; Telliez, Jean-Baptiste; Martin, David; Lejeune, Alexandre

Oral Probenecid for Nonhospitalized Adults with Symptomatic Mild-to-Moderate COVID-19

VIRUSES-BASEL

IF3.5

2023-07-06

OAAI

Martin, David E.; Pandey, Neelam; Chavda, Purvi; Singh, Gurpreet; Sutariya, Rakesh; Sancilio, Frederic; Tripp, Ralph A.

Predictors of Discharge Home Without Opioids After Cardiac Surgery: A Multicenter Analysis

ANNALS OF THORACIC SURGERY

IF3.9

2022-12-01

PREAI

Wagner, Catherine M.; Clark, Melissa J.; Theurer, Patricia F.; Lall, Shelly C.; Nemeh, Hassan W.; Downey, Richard S.; Martin, David E.; Dabir, Reza R.; Asfaw, Zewditu E.; Robinson, Phillip L.; Harrington, Steven D.; Gandhi, Divyakant B.; Waljee, Jennifer F.; Englesbe, Michael J.; Brummett, Chad M.; Prager, Richard L.; Likosky, Donald S.; Kim, Karen M.; Lagisetty, Kiran H.; Brescia, Alexander A.

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication

VIRUSES-BASEL

IF3.5

2022-04-27

OAAI

Murray, Jackelyn; Bergeron, Harrison C.; Jones, Les P.; Reener, Zachary Beau; Martin, David E.; Sancilio, Fred D.; Tripp, Ralph A.

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication 重新利用丙磺舒来抑制SARS-CoV-2，流感病毒和呼吸道合胞病毒病毒 (RSV) 复制

VIRUSES-BASEL

IF3.5

2022-03-15

OAAI

Tripp, Ralph A.; Martin, David E.

Establishment and Implementation of Evidence-Based Opioid Prescribing Guidelines in Cardiac Surgery

ANNALS OF THORACIC SURGERY

IF3.9

2021-10-01

OAAI

Brescia, Alexander A.; Clark, Melissa J.; Theurer, Patricia F.; Lall, Shelly C.; Nemeh, Hassan W.; Downey, Richard S.; Martin, David E.; Dabir, Reza R.; Asfaw, Zewditu E.; Robinson, Phillip L.; Harrington, Steven D.; Gandhi, Divyakant B.; Waljee, Jennifer F.; Englesbe, Michael J.; Brummett, Chad M.; Prager, Richard L.; Likosky, Donald S.; Kim, Karen M.; Lagisetty, Kiran H.

Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro

SCIENTIFIC REPORTS

IF3.9

2021-09-10

OAAI

Murray, Jackelyn; Hogan, Robert J.; Martin, David E.; Blahunka, Kathy; Sancilio, Fred D.; Balyan, Rajiv; Lovern, Mark; Still, Richard; Tripp, Ralph A.

Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses

ARTHRITIS & RHEUMATOLOGY

IF10.9

2021-05-28

OAAI

Bing, Nan; Zhou, Huanyu; Chen, Xing; Hirose, Tomohiro; Kochi, Yuta; Tsuchida, Yumi; Ishigaki, Kazuyoshi; Sumitomo, Shuji; Fujio, Keishi; Zhang, Baohong; Valdez, Hernan; Vincent, Michael S.; Martin, David; Clark, James D.

研究方向